Literature DB >> 27477215

Minimalist Antibodies and Mimetics: An Update and Recent Applications.

Virginia J Bruce1, Angeline N Ta1, Brian R McNaughton2,3.   

Abstract

The immune system utilizes antibodies to recognize foreign or disease-relevant receptors, initiating an immune response to destroy unwelcomed guests. Because researchers can evolve antibodies to bind virtually any target, it is perhaps unsurprising that these reagents, and their small-molecule conjugates, are used extensively in clinical and basic research environments. However, virtues of antibodies are countered by significant challenges. Foremost among these is the need for expression in mammalian cells (largely due to often necessary post-translational modifications). In response to these challenges, researchers have developed an array of minimalist antibodies and mimetics, which are smaller, more stable, simpler to express in Escherichia coli, and amendable to laboratory evolution and protein engineering. Here we describe these scaffolds and discuss recent applications of minimalist antibodies and mimetics.
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Fab fragments; antibodies; monobodies; nanobodies; protein engineering

Mesh:

Substances:

Year:  2016        PMID: 27477215     DOI: 10.1002/cbic.201600303

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  8 in total

1.  Evaluation of Nanobody Conjugates and Protein Fusions as Bioanalytical Reagents.

Authors:  Virginia J Bruce; Brian R McNaughton
Journal:  Anal Chem       Date:  2017-03-20       Impact factor: 6.986

Review 2.  Engineered protein scaffolds as leads for synthetic inhibitors of protein-protein interactions.

Authors:  Michael G Wuo; Paramjit S Arora
Journal:  Curr Opin Chem Biol       Date:  2018-05-24       Impact factor: 8.822

Review 3.  Imaging Translational and Post-Translational Gene Regulatory Dynamics in Living Cells with Antibody-Based Probes.

Authors:  Kenneth Lyon; Timothy J Stasevich
Journal:  Trends Genet       Date:  2017-03-27       Impact factor: 11.639

4.  Engineering selective competitors for the discrimination of highly conserved protein-protein interaction modules.

Authors:  Charlotte Rimbault; Kashyap Maruthi; Christelle Breillat; Camille Genuer; Sara Crespillo; Virginia Puente-Muñoz; Ingrid Chamma; Isabel Gauthereau; Ségolène Antoine; Coraline Thibaut; Fabienne Wong Jun Tai; Benjamin Dartigues; Dolors Grillo-Bosch; Stéphane Claverol; Christel Poujol; Daniel Choquet; Cameron D Mackereth; Matthieu Sainlos
Journal:  Nat Commun       Date:  2019-10-04       Impact factor: 14.919

Review 5.  Escherichia coli surface display for the selection of nanobodies.

Authors:  Valencio Salema; Luis Ángel Fernández
Journal:  Microb Biotechnol       Date:  2017-08-03       Impact factor: 5.813

Review 6.  Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.

Authors:  Michael R Pranzatelli
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

7.  Identification and characterization of a novel Sso7d scaffold-based binder against Notch1.

Authors:  Tenzin Gocha; Balaji M Rao; Ramanuj DasGupta
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

8.  Evaluating Tools for Live Imaging of Structural Plasticity at the Axon Initial Segment.

Authors:  Adna S Dumitrescu; Mark D Evans; Matthew S Grubb
Journal:  Front Cell Neurosci       Date:  2016-11-23       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.